Philip Morris (NYSE: PM) sets $1.47 per-share quarterly dividend
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Philip Morris International Inc. is declaring a regular quarterly dividend of $1.47 per common share, payable on July 20, 2026 to shareholders of record as of June 25, 2026. The ex-dividend date is also June 25, 2026.
The company highlights its focus on smoke-free products, which were used by over 43 million legal-age consumers as of December 31, 2025 and generated 43% of total net revenues in the first quarter of 2026. Since 2008, PMI has invested over $16 billion in developing and commercializing innovative smoke-free products.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Quarterly dividend: $1.47 per common share
Dividend payable date: July 20, 2026
Record and ex-dividend date: June 25, 2026
+3 more
6 metrics
Quarterly dividend
$1.47 per common share
Declared June 11, 2026
Dividend payable date
July 20, 2026
Quarterly dividend payment date
Record and ex-dividend date
June 25, 2026
Shareholders of record and ex-dividend date
Smoke-free consumers
Over 43 million
Users of smoke-free products as of December 31, 2025
Smoke-free revenue share
43% of total net revenues
Contribution in first-quarter 2026
Investment in smoke-free products
Over $16 billion
Cumulative investment since 2008
Key Terms
ex-dividend date, smoke-free products, Modified Risk Tobacco Product, heat-not-burn, +2 more
6 terms
ex-dividend date financial
"The ex-dividend date is June 25, 2026."
The ex-dividend date is the date when a stock starts trading without the value of its next dividend payment included. If you buy the stock on or after this date, you won't receive that upcoming dividend; only those who owned the stock before this date are entitled to it. It matters to investors because it determines who is eligible to receive the dividend and can influence the stock’s price around that time.
smoke-free products financial
"The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products."
Modified Risk Tobacco Product regulatory
"Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA."
A modified risk tobacco product is a tobacco or nicotine product that is marketed with claims it reduces health risks or exposure to harmful substances compared with other tobacco products; such claims are typically subject to regulatory review and approval. For investors, this matters because approved modified-risk status can change consumer demand, legal exposure, labeling requirements and market access—similar to how a government-backed “low-risk” label can alter a product’s sales and liability profile.
heat-not-burn technical
"The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products."
A heat-not-burn product is a consumer device that warms processed tobacco or nicotine material to generate an inhalable aerosol without burning it, similar to how a hot plate steams food instead of frying it. Investors watch these products because they can change demand for traditional cigarettes, face distinct regulatory and legal risks, and influence long-term revenue and public perception in tobacco and nicotine markets.
nicotine pouches technical
"the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches"
Nicotine pouches are small, discreet packets containing nicotine and flavoring that are placed between the lip and gum to release nicotine without burning tobacco or producing smoke. Think of them like a tiny, flavored tea bag that releases a stimulant into the mouth; they offer an alternative delivery method to cigarettes and vaping. Investors watch them because they can grow sales in markets shifting away from smoking, but they also carry regulatory, public-health and liability risks that can affect profits and market value.
net revenues financial
"The smoke-free business accounted for 43% of PMI’s first-quarter 2026 total net revenues."
Net revenues represent the total amount of money a company earns from its main business activities after subtracting refunds, discounts, and returns. It shows the actual income generated from sales that the company keeps. For investors, net revenues provide a clearer picture of a company's true sales performance and help assess its overall financial health.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 11, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||||||||
Registrant's telephone number, including area code: (203 ) 905-2410
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |||||
Emerging growth company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||||
| Item 7.01. | Regulation FD Disclosure. | ||||
On June 11, 2026, Philip Morris International Inc. issued a press release announcing that its Board of Directors declared a regular quarterly dividend of $1.47 per common share, which press release is attached as Exhibit 99.1 to this Item 7.01 of this Current Report on Form 8-K and incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such filing or document.
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) | Exhibits. | ||||
| 99.1 | Philip Morris International Inc. Press Release, dated June 11, 2026 (furnished pursuant to Item 7.01). | ||||
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL). | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PHILIP MORRIS INTERNATIONAL INC. | ||||||||
| By: | /s/ DARLENE QUASHIE HENRY | |||||||
| Name: | Darlene Quashie Henry | |||||||
| Title: | Vice President, Associate General Counsel & Corporate Secretary | |||||||
Date: June 11, 2026
Exhibit 99.1
| PRESS RELEASE |  | |||||||||||||
| Investor Relations: | Media: | |||||||||||||
Email: InvestorRelations@pmi.com | Email: Corey.Henry@pmi.com | |||||||||||||
| Stamford, CT: +1 (203) 905 2413 | Stamford, CT: +1 (203) 905 2410 | |||||||||||||
| Lausanne: +41 582 424 500 | ||||||||||||||
Philip Morris International
Declares Regular Quarterly Dividend of $1.47 Per Share
Declares Regular Quarterly Dividend of $1.47 Per Share
STAMFORD, CT, June 11, 2026 – The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.47 per common share, payable on July 20, 2026, to shareholders of record as of June 25, 2026. The ex-dividend date is June 25, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend.
Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI’s first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 43% of PMI’s first-quarter 2026 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.
FAQ
What dividend did Philip Morris International (PM) declare?
Philip Morris International declared a regular quarterly dividend of $1.47 per common share. This cash dividend reflects the company’s ongoing capital return policy and will be paid to shareholders of record on the specified record date in 2026.
When is the PM quarterly dividend payable and what is the record date?
The $1.47 per-share quarterly dividend is payable on July 20, 2026. Shareholders must be on record as of June 25, 2026 to receive it, with the ex-dividend date also falling on June 25, 2026.
How important are smoke-free products to Philip Morris International’s revenue?
Smoke-free products generated 43% of PMI’s first-quarter 2026 total net revenues. These include heat-not-burn, nicotine pouch and e-vapor products, underscoring the company’s strategic shift toward a smoke-free portfolio and reduced reliance on traditional cigarettes.
How many consumers use Philip Morris International’s smoke-free products?
As of December 31, 2025, PMI estimates its smoke-free products were used by over 43 million legal-age consumers. Many of these consumers have moved away from cigarettes or significantly reduced their consumption by switching to the company’s alternative products.
How much has Philip Morris International invested in smoke-free products?
Since 2008, PMI has invested over $16 billion to develop, substantiate and commercialize smoke-free products. This includes building scientific capabilities in toxicology, clinical, behavioral and post-market research to support its long-term smoke-free strategy.
What FDA authorizations have PMI and Swedish Match products received?
The U.S. FDA has authorized marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables. Certain IQOS and General snus products also received the first-ever Modified Risk Tobacco Product authorizations.
Where can investors find more information on PM’s dividends?
Investors can find more details on Philip Morris International’s stock and dividends at www.pmi.com/dividend. The site provides historical dividend information, upcoming payment details, and related shareholder resources maintained by the company.